The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Roche; Roche; Tesaro
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Roche; Tesaro
EUDARIO/ENGOTov-48: A European multicenter randomised phase II trial on the combination of the HSP90 inhibitor ganetespib with carboplatin followed by maintenance treatment with niraparib (+/- ganetespib) compared to platinum-based combination-chemotherapy followed by niraparib in relapsed platinum-sensitive ovarian cancer patients.
 
Nicole Concin
Consulting or Advisory Role - Seagen
Travel, Accommodations, Expenses - Genmab; Roche Belgium
 
Domenica Lorusso
No Relationships to Disclose
 
Ioana Braicu
Honoraria - AstraZeneca; Clovis Oncology; CRA International; Incyte; Roche Pharma AG; Tesaro
Consulting or Advisory Role - Clovis Oncology; CRA International; Roche Pharma AG; Seagen; Tesaro
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche Pharma AG; Tesaro
 
Isabelle Laure Ray-Coquard
Honoraria - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - Abbvie; Amgen; Genmab; Pfizer
Travel, Accommodations, Expenses - Roche
 
Florence Joly
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD Oncology; Pfizer; Roche; Sanofi; Tesaro
Research Funding - Astellas Pharma; Janssen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Roche; tesaro
 
Philipp Harter
Honoraria - AstraZeneca; Lilly; PharmaMar; Roche; Stryker; Tesaro; Zai Lab
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Lilly; PharmaMar; Roche; Tesaro
 
Pauline Wimberger
Honoraria - Tesaro
Consulting or Advisory Role - Tesaro
 
Jean-Pierre Lotz
No Relationships to Disclose
 
Alain G Zeimet
No Relationships to Disclose
 
Giovanni Scambia
No Relationships to Disclose
 
Barbara Schmalfeldt
Honoraria - AstraZeneca; Ethicon; Roche; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; MSD; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Claudio Zamagni
Honoraria - Istituto Gentili; Pierre Fabre; Takeda; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Eisai; Lilly; Novartis; Pfizer; PharmaMar; QuintilesIMS; Roche; Tesaro
Research Funding - Abbvie (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Celgene (Inst); Medivation (Inst); Morphotek (Inst); Novartis (Inst); pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Seagen (Inst); Synthon (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Celgene; Istituto Gentili; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche; Tesaro
 
Francesco Raspagliesi
No Relationships to Disclose
 
Alexander Mustea
Consulting or Advisory Role - AstraZeneca; Roche
 
Hanno Ulmer
No Relationships to Disclose
 
Daniela Kramer
No Relationships to Disclose
 
Matthias Dobbelstein
No Relationships to Disclose
 
Eric Pujade-Lauraine
Honoraria - AstraZeneca; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Incyte; Merck; Pfizer/EMD Serono; Roche; TESARO
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro
Other Relationship - Arcagy-Gineco
 
Jalid Sehouli
Honoraria - AstraZeneca; Clovis Oncology; Eisai; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Merck; MSD Oncology; Pfizer; PharmaMar; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche Pharma AG; Tesaro; Tesaro
 
Ignace Vergote
Consulting or Advisory Role - Advaxis (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (Inst); Genmab (Inst); Immunogen (Inst); Millennium (Inst); MSD Belgium (Inst); Oncoinvent (Inst); PharmaMar (Inst); Roche (Inst); Roche (Inst); Sotio (Inst); Tesaro (Inst)
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst); Stichting tegen kanker (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genmab; PharmaMar; Roche; Takeda; Tesaro